Authors

• Lu Si (ORCID: https://orcid.org/0000-0002-2123-9761)
• Hui Tian (ORCID: https://orcid.org/0000-0002-8419-5954)
• Xinan Sheng (ORCID: https://orcid.org/0000-0001-9359-0975)
• Bixia Tang (ORCID: https://orcid.org/0000-0002-3458-461X)
• Xiaoting Wei (ORCID: https://orcid.org/0009-0006-1916-0890)
• Xiangyong Gu
• Jun Guo
• Bin Lian (ORCID: https://orcid.org/0000-0003-0090-1290)
• Zhihong Chi (ORCID: https://orcid.org/0009-0005-1504-7842)
• Binlei Liu (ORCID: https://orcid.org/0000-0002-2852-600X)
• Li Zhou (ORCID: https://orcid.org/0000-0002-9331-0600)
• Juan Li (ORCID: https://orcid.org/0000-0002-9838-0990)
• Siming Li (ORCID: https://orcid.org/0000-0002-2879-2113)
• Caili Li (ORCID: https://orcid.org/0000-0003-0967-6077)
• Yan Kong (ORCID: https://orcid.org/0000-0002-6368-2112)
• Han Hu (ORCID: https://orcid.org/0000-0002-8188-6143)
• Xieqiao Yan (ORCID: https://orcid.org/0000-0002-1781-3193)
• Lili Mao
• Chuanliang Cui (ORCID: https://orcid.org/0000-0001-6455-0843)
• Xuan Wang (ORCID: https://orcid.org/0000-0002-4160-0761)

Institutions

• Peking University (CN)
• Peking University Cancer Hospital (CN)
• Ministry of Education (ET)
• Wuhan YZY Biopharma (China) (CN)
• Hubei University of Technology (CN)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2025-02-01

DOI

https://doi.org/10.1136/jitc-2024-010662

Citations

16

Primary Topic

Virus-based gene therapy research

Type

article

Field-Weighted Citation Impact

29.08

Funders

• Shanghai Junshi Biosciences
• Peking University
• Beijing Municipal Administration of Hospitals